Physician profile
Steven Disegna
NPI 1790128650
$4,488.68
in general payments reported to CMS, 2019-2025
9 companies · $748 in 2025
The $748 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $181 · 2021: $2,322 · 2022: $153 · 2023: $528 · 2024: $220 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292 · Travel and Lodging: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.95 |
| Travel and Lodging | $204.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,911.75 | 2019-2025 | Mako, Gamma, Triathlon |
| Encore Medical, LP | $1,652.73 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $602.78 | 2019-2025 | Oxford, Avenir, Mymobility Platform |
| Smith+Nephew, INC. | $126.80 | 2020 | |
| Medical Device Business Services, INC. | $58.82 | 2019-2022 | |
| Depuy Synthes Sales INC. | $54.65 | 2021 | |
| Conformis, INC. | $41.10 | 2021 | |
| Endo USA, INC. | $23.74 | 2024 | Xiaflex |
| Ferring Pharmaceuticals INC. | $16.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Disegna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.